Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension

Mei-Sing Ong1, Mary P Mullen2, Eric D Austin2

  • 1From the Computational Health Informatics Program (M.-S.O., M.D.N., A.G., S.W.K., K.D.M.), Department of Cardiology (M.P.M.), Division of Critical Care Medicine, Department of Anesthesiology, Perioperative, and Pain Medicine (A.G.), and Department of Anesthesia (A.G.), Harvard School of Medicine, Boston Children's Hospital, MA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN (E.D.A.); Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge (P.S.); Department of Pediatrics, Massachusetts General Hospital, Boston (M.D.N.); and Department of Biostatistics, Harvard School of Public Health, Boston, MA. (T.C.). mei-sing_ong@hms.harvard.edu.

Circulation Research
|June 15, 2017
PubMed

Insights

Network science analysis of pediatric pulmonary hypertension (PH) comorbidities identified known and rare disease subtypes. This approach aids in refining PH classification and understanding its diverse manifestations in children.

Area of Science:

  • Pediatric Pulmonology
  • Computational Biology
  • Network Science

Background:

  • Pediatric pulmonary hypertension (PH) is a complex condition with varied clinical presentations and treatment responses.
  • Accurate classification of pediatric PH subtypes is essential for personalized patient care.
  • Current understanding of the full spectrum of pediatric PH remains incomplete.

Purpose of the Study:

  • To investigate the clinical manifestations of PH in children.
  • To evaluate the utility of a network-based approach for identifying PH subtypes using comorbidity data.
  • To enhance the classification of pediatric PH.

Main Methods:

  • Retrospective cohort study of 6,943,263 children in the US (2010-2013).
  • Identified 1583 children with PH and analyzed associated comorbidities.
  • Constructed a Bayesian comorbidity network and applied clustering analysis to derive disease subtypes.

Main Results:

  • 186 comorbidities were significantly associated with pediatric PH.
  • Network analysis successfully identified established PH subtypes based on WHO and Panama classifications.
  • The study uncovered rare PH subtypes linked to genetic syndromes, previously identified only in limited case studies.

Conclusions:

  • Network science offers a powerful method for discovering disease subtypes from longitudinal comorbidity data.
  • This validated approach successfully identified known PH subtypes and revealed rare ones.
  • The findings provide a basis for further research to enrich existing pediatric PH classifications.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
724
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K